Annual report pursuant to Section 13 and 15(d)

Intangible Assets - License Agreements (Details)

v3.8.0.1
Intangible Assets - License Agreements (Details) - USD ($)
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Sales and Marketing Expense      
Intangible assets      
Royalty fees included in sales and marketing expense $ 1,200,000 $ 812,000 $ 526,000
License Agreements      
Intangible assets      
License agreements extended period 60 days    
Minimum royalty of agreements $ 12,500    
Milestone fee upon receiving a Phase II Small Business Innovation Research 15,000    
Milestone fee upon FDA approval 2,000    
Milestone fee upon first commercial use of certain licensed technology 25,000    
Milestone fee upon first use to manufacture products that utilize certain technology not currently incorporated into AxoGen products $ 10,000    
License Agreements | Minimum      
Intangible assets      
Royalty fees range under the license agreements 1.00%    
License Agreements | Maximum      
Intangible assets      
Royalty fees range under the license agreements 3.00%    
Royalty stack cap for royalties paid to more than one licensor for sales of the same product 3.75%